• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma


65.65 CHF 0.50 0.76%

As of 11:43:49 ET on 12/23/2014.

Snapshot for AbbVie Inc (ABBV)

Open: 65.65 Day's Range: 62.79 - 62.80 Volume: 0
Previous Close: 66.15 52wk Range: 40.85 - 71.00 1-Yr Rtn: +44.17%

Stock Chart for ABBV

No chart data available.
  • ABBV:SW 65.65
  • 1M
  • 1Y
Interactive ABBV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ABBV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 20.2340
Relative P/E vs. SMI -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 3.3030
Est. PEG Ratio 2.2907
Market Cap (M CHF) 104,610.12
Shares Outstanding (M) 1,593.45
30 Day Average Volume 104
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.94%
Cash Dividend (USD) 0.4900
Dividend Ex-Date 01/13/2015
5 Year Dividend Growth -
Next Earnings Announcement 01/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ABBV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ABBV

AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.

Richard A Gonzalez "Rick"Chairman/CEOWilliam J ChaseExec VP/CFO
Michael Severino "Mike"Exec VP:Research & DevelopmentLaura J SchumacherExec VP:Bus Dev/Secy /Gen Cnsl
More Company Profile & Key Executives for ABBV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil